Literature DB >> 15486144

Thrombolytic treatment in diabetic patients with acute myocardial infarction: lower rates of use than in non-diabetic patients are explained by differences in presenting ECGs.

E Kvan, A Reikvam.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15486144      PMCID: PMC1768515          DOI: 10.1136/hrt.2003.026724

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

Authors:  Michel E Bertrand; Maarten L Simoons; Keith A A Fox; Lars C Wallentin; Christian W Hamm; Eugene McFadden; Pim J De Feyter; Giuseppe Specchia; Witold Ruzyllo
Journal:  Eur Heart J       Date:  2002-12       Impact factor: 29.983

2.  Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. European Secondary Prevention Study Group.

Authors: 
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

Review 3.  Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus.

Authors:  K H Mak; E J Topol
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

4.  Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.

Authors:  Anna Norhammar; Klas Malmberg; Lars Rydén; Per Tornvall; Ulf Stenestrand; Lars Wallentin
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

5.  Use of cardiovascular drugs after acute myocardial infarction: a marked shift towards evidence-based drug therapy.

Authors:  Asmund Reikvam; Elena Kvan; Ivar Aursnes
Journal:  Cardiovasc Drugs Ther       Date:  2002-09       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.